Eli Lilly and Company Limited

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com.

Role within ImmUniverse

Lilly scientists will leverage their collective expertise gained from running multiple phase 3 trials in both Ulcerative Colitis and Atopic Dermatitis. This includes sharing of best practices of biosampling as well as contribution of select samples collected from Lilly clinical trials. In addition, Lilly will contribute their expertise in data analyses by applying bioinformatics and analytical approaches. Finally, Lilly will contribute their insights in biomarker identification and assay development. Lilly will co-lead the clinical trial hub (work package 6) and actively contribute to specific tasks as needed to support and contribute to the success of ImmUniverse.

Main Contacts

Robert Benschop PhD
Robert Benschop PhD
Senior Director
John Kwon MD PhD
John Kwon MD PhD
Senior Medical Advisor
Cem Kayhan MD
Cem Kayhan MD
Medical Fellow
Jochen Schmitz PhD
Jochen Schmitz PhD
Research Advisor
Ernst Dow PhD
Ernst Dow PhD
Research Advisor
Klaus Gottlieb MD
Klaus Gottlieb MD
Medical Fellow
Birgit Steckel-Hamann PhD
Birgit Steckel-Hamann PhD
Head of IMI Operations